Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells.

Saved in:
Bibliographic Details
Title: Author Correction: Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells.
Authors: Huang D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Tran JT; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Olson A; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Vollbrecht T; Department of Medicine, The University of California San Diego, La Jolla, CA, USA., Tenuta M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Guryleva MV; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Faculty of Bioengineering and Bioinformatics, Moscow Lomonosov State University, Moscow, Russia., Fuller RP; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA., Schiffner T; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA., Abadejos JR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Couvrette L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Faculty of Science, University of Ottawa, Ottawa, Canada., Blane TR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Saye K; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA., Li W; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Landais E; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA., Gonzalez-Martin A; Department of Biochemistry, Universidad Autónoma de Madrid (UAM) and Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid, Spain., Schief W; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA., Murrell B; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. benjamin.murrell@ki.se., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; Scripps Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; IAVI Neutralizing Antibody Center (IAVI), The Scripps Research Institute, La Jolla, CA, USA. burton@scripps.edu.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA, USA. burton@scripps.edu., Nemazee D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. nemazee@scripps.edu., Voss JE; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. jvoss@scripps.edu.
Source: Nature communications [Nat Commun] 2020 Dec 07; Vol. 11 (1), pp. 6360. Date of Electronic Publication: 2020 Dec 07.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2041-1723
DOI:10.1038/s41467-020-20304-y